MacroGenics (MGNX)
(Delayed Data from NSDQ)
$3.06 USD
-0.22 (-6.71%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $3.05 -0.01 (-0.33%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
MacroGenics (MGNX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$7.44 | $14.00 | $4.00 | 126.83% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for MacroGenics comes to $7.44. The forecasts range from a low of $4.00 to a high of $14.00. The average price target represents an increase of 126.83% from the last closing price of $3.28.
Analyst Price Targets (9 )
Broker Rating
MacroGenics currently has an average brokerage recommendation (ABR) of 2.17 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 2.27 a month ago based on 11 recommendations.
Of the 12 recommendations deriving the current ABR, five are Strong Buy, representing 41.67% of all recommendations. A month ago, Strong Buy represented 36.36%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 4 | 4 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 7 | 7 | 7 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.17 | 2.27 | 2.27 | 1.73 | 1.73 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/16/2024 | Cowen & Co. | Tara Bancroft | Hold | Hold |
9/16/2024 | Evercore Partners | Research Department | Not Available | Strong Buy |
9/16/2024 | Not Identified | Not Identified | Hold | Hold |
8/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/1/2024 | BTIG | Kaveri Pohlman | Strong Buy | Hold |
8/1/2024 | H.C. Wainwright & Co. | Robert Burns | Hold | Hold |
7/31/2024 | Guggenheim Securities | Michael Schmidt | Strong Buy | Hold |
7/31/2024 | JMP Securities | Silvan C Tuerkcan | Strong Buy | Strong Buy |
7/31/2024 | B. Riley Securities | Mayank Mamtani | Hold | Hold |
7/30/2024 | SVB Securities | Jonathan W Chang | Strong Buy | Strong Buy |
7/29/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/10/2024 | BMO Capital Markets | Etzer Darout | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.17 |
ABR (Last week) | 2.27 |
# of Recs in ABR | 12 |
Average Target Price | $7.44 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | 0.08 |
MGNX FAQs
MacroGenics, Inc. (MGNX) currently has an average brokerage recommendation (ABR) of 2.17 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms.
The average price target for MacroGenics, Inc. (MGNX) is $7.44. The current on short-term price targets is based on 5 reports.
The forecasts for MacroGenics, Inc. (MGNX) range from a low of $4 to a high of $14. The average price target represents a increase of $143.14 from the last closing price of $3.06.
The current UPSIDE for MacroGenics, Inc. (MGNX) is 143.14%
Based on short-term price targets offered by nine analysts, the average price target for MacroGenics comes to $7.44. The forecasts range from a low of $4.00 to a high of $14.00. The average price target represents an increase of 126.83% from the last closing price of $3.28.